AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
Launched by ZHEN WANG · Jan 9, 2025
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Graduate or regulatory trainee, currently rotating in cardiology and willing to participate in research.
- • Age between 18-30 years old, gender not limited.
- • No specialized training experience in hypertension diagnosis and treatment, only possessing basic medical theoretical knowledge.
- • Able to accept a 4-week teaching intervention (2 hours of study per week).
- • Sign the informed consent form and be aware of the research purpose and process.
- Exclusion Criteria:
- • Graduate students or trained interns who have received specialized training in hypertension medication treatment.
- • Students unable to complete the full course of study (e.g., rotations shorter than four weeks or potential mid-course withdrawal).
- • Unable to consistently participate in educational interventions (e.g., conflicts with study schedule).
- • Have severe physical or mental health issues that may affect the learning process.
- • Have language comprehension barriers or cognitive impairments, making it difficult to complete learning tasks.
About Zhen Wang
Zhen Wang is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a commitment to ethical practices and regulatory compliance, Zhen Wang collaborates with leading researchers and healthcare professionals to design and implement rigorous clinical studies. The organization emphasizes transparency, data integrity, and patient safety, ensuring that all trials are conducted with the highest standards of quality. By fostering partnerships and leveraging cutting-edge technologies, Zhen Wang aims to accelerate the development of effective treatments across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hefei, Anhui, China
Patients applied
Trial Officials
xianrui luo
Study Chair
The Second Hospital of Anhui Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported